Gamida Cell Presents Omidubicel Phase 3 Data in Patients with High-Risk Hematologic Malignancies
Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]
AstraZeneca’s Calquence Meets Primary Efficacy Endpoint in Head-to-Head Trial Against Ibrutinib in Chronic Lymphocytic Leukemia
AstraZeneca reported positive results from the phase 3 ELEVATE-RR trial, which evaluated AstraZeneca’s Calquence (acalabrutinib) versus ibrutinib in adults with previously treated, […]
Agios Reports Data from Phase 3 ACTIVATE-T Trial of Mitapivat in Regularly Transfused Adults with PK Deficiency
Agios Pharmaceuticals announced results from the phase 3 ACTIVATE-T trial of mitapivat in regularly transfused adults with Pyruvate Kinase (PK) deficiency. […]
BioMarin Reports Top-Line Results from Phase 3 Gene Therapy Study in Adults with Hemophilia A
BioMarin announced positive topline results from its ongoing global Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy […]
Constellation Pharma Reports Initial Data from MANIFEST Trials of CPI-0610 for Myelofibrosis
Constellation Pharmaceuticals announced positive preliminary data from its Phase II MANIFEST and Phase III MANIFEST-2 clinical trials evaluating CPI-0610 for […]
Baylor College of Medicine Secures $1.4m to Fund a CAR T Cell-based Clinical Trial Investigating Advanced Sarcoma in Children
A Baylor College of Medicine and Texas Children’s Cancer Center research team has been awarded a $1.4 million gift over […]
uniQure Reports Positive Top-Line Data from HOPE-B Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B
Uniqure announced positive top-line data from its pivotal, Phase III HOPE-B gene therapy trial of etranacogene dezaparvovec, an adeno-associated virus five […]
GenMab’s Daratumumab Slows Multiple Myeloma Disease Progression in Phase 3 CASSIOPEIA Trial
GenMab announced positive topline results from the second part of the Phase 3 CASSIOPEIA (MMY3006) study of daratumumab monotherapy as […]
UT Southwestern Investigators Head Nationwide Studies Investigating Childhood Blood Disorders
UT Southwestern research shows the effectiveness of a treatment for aplastic anemia while revealing a range of diagnosis and treatment […]
Astex and Otsuka Announce Phase 3 ASTRAL-2 and ASTRAL-3 Studies Fail to Meet Endpoints in Patients with Previously Treated AML and MDS
Astex Pharmaceuticals and Otsuka Pharmaceuticals announced top-line results of the ASTRAL-2 and ASTRAL-3 clinical studies that evaluated the efficacy and […]
